Nelsen Robert

EDGAR CIK 0001219042

Prime Medicine, Inc. - PRME

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$20.00 M
3,200,000 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
02/15/2024
02/20/2024
Buy
3,200,000 @ $6.25
 $20,000,000 3,200,000 (100.00%) Indirect - By ARCH Venture Fund XII, L.P.

Sana Biotechnology, Inc. - SANA

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Director 10% owner
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
1
$10.00 M
1,818,181 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
02/08/2024
02/12/2024
Buy
1,818,181 @ $5.50
 $9,999,996 12,446,022 (17.11%) Indirect - See Footnote